RecruitingNCT05978466

MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

Sponsor

CorVita Science Foundation

Enrollment

1,000 participants

Start Date

Dec 22, 2017

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation

Summary

The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study collecting long-term data on how atrial fibrillation (AF) — an irregular heart rhythm — is managed and how patients fare over time. It aims to track real-world outcomes across different treatment approaches. **You may be eligible if...** - You are 18 or older - You have been diagnosed with atrial fibrillation (valvular or non-valvular) - Your diagnosis has been confirmed by at least one of: ECG, Holter monitor, event monitor, or implantable loop recorder - You are able to attend clinic follow-ups at least once a year **You may NOT be eligible if...** - You are under 18 years old - There is a concern that you may pass away within 6 months - You are unable to provide informed consent - You cannot attend regular follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

CorVita Science Foundation (NFP)

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05978466

Related Trials

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

NCT046951061 location

Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT050148023 locations